Feasibility and safety of magnetic resonance imaging-based thrombolysis in patients with stroke on awakening: Initial single-centre experience

International Journal of Stroke

Volumn 5, Issue 2, 2010, Pages 68-73

  Breuer, L ^a   Schellinger, P D ^a   Huttner, H B ^a   Halwachs, R ^a   Engelhorn, T ^a   Doerfler, A ^a   Kohrmann M ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

Author keywords

Acute ischaemic stroke; PWI DWI mismatch; Thrombolysis; Wake up stroke

Indexed keywords

FIBRINOLYTIC AGENT;

ADULT; AGED; AROUSAL; ARTICLE; BLOOD CLOT LYSIS; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; FEASIBILITY STUDY; FEMALE; HOSPITAL DISCHARGE; HUMAN; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; RANKIN SCALE; SYMPTOMATOLOGY;

ADULT; AGED; AGED, 80 AND OVER; BRAIN; FEMALE; FIBRINOLYTIC AGENTS; HUMANS; INFUSIONS, INTRAVENOUS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOGNITION (PSYCHOLOGY); SAFETY; SLEEP; STROKE; THROMBOLYTIC THERAPY; TOMOGRAPHY, X-RAY COMPUTED; WAKEFULNESS;

EID: 77951230915     PISSN: 17474930     EISSN: 17474949     Source Type: Journal    
DOI: 10.1111/j.1747-4949.2010.00410.x     Document Type: Article

References (26)

1. Chaturvedi S, Adams HP, Woolson RF. Circadian variation in ischemic stroke subtypes. Stroke 1999, 30:1792-5.
2. Lago A, Geffner D, Tembl J, Landete L, Valero C, Baquero M. Circadian variation in acute ischemic stroke: a hospital-based study. Stroke 1998, 29:1873-5.
3. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 1995, 333:1581-7.
4. Fink JN, Kumar S, Horkan C. The stroke patient who woke up: clinical and radiological features, including diffusion and perfusion MRI. Stroke 2002, 33:988-93.
5. Serena J, Davalos A, Segura T, Mostacero E, Castillo J. Stroke on awakening: looking for a more rational management. Cerebrovasc Dis 2003, 16:128-33.
6. Todo K, Moriwaki H, Saito K, Tanaka M, Oe H, Naritomi H. Early CT findings in unknown-onset and wake-up strokes. Cerebrovasc Dis 2006, 21:367-71.
7. Adams HP, Effron MB, Torner J. Emergency administration of abciximab for treatment of patients with acute ischemic stroke: results of an international phase III trial: Abciximab in Emergency Treatment of Stroke Trial (AbESTT-II). Stroke 2008, 39:87-99.
8. Kohrmann M, Juttler E, Fiebach JB. MRI versus CT-based thrombolysis treatment within and beyond the 3 h time window after stroke onset: a cohort study. Lancet Neurol 2006, 5:661-7.
9. Schellinger PD, Thomalla G, Fiehler J. MRI-based and CT-based thrombolytic therapy in acute stroke within and beyond established time windows: an analysis of 1210 patients. Stroke 2007, 38:2640-5.
10. Thomalla G, Schwark C, Sobesky J. Outcome and symptomatic bleeding complications of intravenous thrombolysis within 6 hours in MRI-selected stroke patients: comparison of a German multicenter study with the pooled data of ATLANTIS, ECASS, and NINDS tPA trials. Stroke 2006, 37:852-8.
11. Hacke W, Albers G, Al-Rawi Y. The Desmoteplase in Acute Ischemic Stroke Trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke 2005, 36:66-73.
12. Furlan AJ, Eyding D, Albers GW. Dose Escalation of Desmoteplase for Acute Ischemic Stroke (DEDAS): evidence of safety and efficacy 3 to 9 hours after stroke onset. Stroke 2006, 37:1227-31.
13. Adams HP, Leira EC, Torner JC. Treating patients with 'wake-up' stroke: the experience of the AbESTT-II trial. Stroke 2008, 39:3277-82.
14. The European Stroke Organisation (ESO) Executive Committee and the ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008, 25:457-507.
15. Hjort N, Butcher K, Davis SM. Magnetic resonance imaging criteria for thrombolysis in acute cerebral infarct. Stroke 2005, 36:388-97.
16. Hacke W, Kaste M, Bluhmki E. Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke. N Engl J Med 2008, 359:1317-29.
17. Schellinger PD, Jansen O, Fiebach JB. Feasibility and practicality of MR imaging of stroke in the management of hyperacute cerebral ischemia. Am J Neuroradiol 2000, 21:1184-9.
18. Buckley BT, Wainwright A, Meagher T, Briley D. Audit of a policy of magnetic resonance imaging with diffusion-weighted imaging as first-line neuroimaging for in-patients with clinically suspected acute stroke. Clin Radiol 2003, 58:234-7.
19. Barber PA, Hill MD, Eliasziw M. Imaging of the brain in acute ischaemic stroke: comparison of computed tomography and magnetic resonance diffusion-weighted imaging. J Neurol Neurosurg Psychiatry 2005, 76:1528-33.
20. Hand PJ, Wardlaw JM, Rowat AM, Haisma JA, Lindley RI, Dennis MS. Magnetic resonance brain imaging in patients with acute stroke: feasibility and patient related difficulties. J Neurol Neurosurg Psychiatry 2005, 76:1525-7.
21. von Kummer R, Dzialowski I. MRI versus CT in acute stroke. Lancet 2007, 369:1341-2.
22. Hellier KD, Hampton JL, Guadagno JV. Perfusion CT helps decision making for thrombolysis when there is no clear time of onset. J Neurol Neurosurg Psychiatry 2006, 77:417-9.
23. Iosif C, Oppenheim C, Trystram D, Domigo V, Meder JF. MR imaging-based decision in thrombolytic therapy for stroke on awakening: report of 2 cases. Am J Neuroradiol 2008, 29:1314-6.
24. Cho AH, Sohn SI, Han MK. Safety and efficacy of MRI-based thrombolysis in unclear-onset stroke. A preliminary report. Cerebrovasc Dis 2008, 25:572-9.
25. Barreto AD, Martin-Schild S, Hallevi H. Thrombolytic therapy for patients who wake-up with stroke. Stroke 2009, 40:827-32.
26. Donnan GA, Davis SM. The ethics of thrombolytic trials beyond 3 (or 4.5) hours: randomized controlled trials are required to change clinical practice. Stroke 2009, 40:1545.